fig1
Figure 1. Flow chart of the use of cerebrospinal fluid biomarkers in clinical practice, according to the AT(N) system[7]. AD: Alzheimer’s disease
Figure 1. Flow chart of the use of cerebrospinal fluid biomarkers in clinical practice, according to the AT(N) system[7]. AD: Alzheimer’s disease
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/